2015, Número 3
<< Anterior Siguiente >>
Med Cutan Iber Lat Am 2015; 43 (3)
Acantose nigricans benigna generalizada: apresentação rara em criança e revisão da literatura
Mota RA, Alves CKP, Dornelas CMAC, de Moraes DM, de Melo AF, Takano DM
Idioma: Portugués
Referencias bibliográficas: 10
Paginas: 213-216
Archivo PDF: 745.48 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Barbato M, Criado PR, Silva AK, Averbeck E, Guerini MB, Sa NB. Associação de acantose nigricante e acrocórdons à resistência insulínica. An Bras Dermatol. 2012; 87 (1): 97-104.
Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J. 2008;14 (9): 2.
Lee HW, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK. Hyperkeratosis of the nipple associated with acanthosis nigricans: treatment with topical calcipotriol. J Am Acad Dermatol. 2005; 52: 529-530.
Adigun CG, Pandya AG. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream. J Eur Acad Dermatol Venereol. 2009; 23 (4): 486-487.
Berk DR, Spector EB, Bayliss SJ. Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol. 2007; 143 (9): 1153-1156.
Rai VM, Balachandran C. Generalized acanthosis nigricans in childhood. Dermatol Online J. 2006; 12 (6): 14.
Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007; 57: 502-508.
Ozdemir M, Toy H, Mevlitoglu I, Demirkesen C. Generalized idiopathic acanthosis nigricans treated with acitretin. J Dermatolog Treat. 2006; 17: 54-56.
Walling HW, Messingham M, Myers LM, Mason CL, Strauss JS. Improvement of acanthosis nigricans on isotretinoin and metformin. J Drugs Dermatol. 2003; 2: 677-681.
Bellot-Rojas P, Posadas-Sanchez R, Caracas-Portilla N, Zamora-Gonzalez J, Cardoso-Saldana G, Jurado-Santacruz F et al. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study. J Drugs Dermatol. 2006; 5: 884-889.